- Home
- SABS vs NXGL Comparison
SABS vs NXGL Comparison
Compare SABS & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- NXGL
- Stock Information
- Founded
- SABS 2014
- NXGL 1997
- Country
- SABS United States
- NXGL United States
- Employees
- SABS N/A
- NXGL N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- SABS Health Care
- NXGL Health Care
- Exchange
- SABS Nasdaq
- NXGL Nasdaq
- Market Cap
- SABS 19.0M
- NXGL 18.9M
- IPO Year
- SABS N/A
- NXGL 2021
- Fundamental
- Price
- SABS $1.25
- NXGL $2.85
- Analyst Decision
- SABS Strong Buy
- NXGL
- Analyst Count
- SABS 5
- NXGL 0
- Target Price
- SABS $11.40
- NXGL N/A
- AVG Volume (30 Days)
- SABS 38.1K
- NXGL 48.6K
- Earning Date
- SABS 05-19-2025
- NXGL 03-24-2025
- Dividend Yield
- SABS N/A
- NXGL N/A
- EPS Growth
- SABS N/A
- NXGL N/A
- EPS
- SABS N/A
- NXGL N/A
- Revenue
- SABS $1,322,410.00
- NXGL $8,688,000.00
- Revenue This Year
- SABS N/A
- NXGL $51.39
- Revenue Next Year
- SABS $25.00
- NXGL $36.14
- P/E Ratio
- SABS N/A
- NXGL N/A
- Revenue Growth
- SABS N/A
- NXGL 112.47
- 52 Week Low
- SABS $1.11
- NXGL $1.84
- 52 Week High
- SABS $5.01
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- SABS 31.17
- NXGL 45.24
- Support Level
- SABS $1.11
- NXGL $2.60
- Resistance Level
- SABS $1.80
- NXGL $3.25
- Average True Range (ATR)
- SABS 0.16
- NXGL 0.23
- MACD
- SABS -0.01
- NXGL 0.03
- Stochastic Oscillator
- SABS 18.42
- NXGL 38.08
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.